COLLABORATION TO DEVELOP EVIDENCE-BASED STRATEGIES TO HELP IMPROVE OSTEOARTHRITIS MANAGEMENT Haleon and University of Sydney launch 5-Year fellowship to research efficacy of dietary supplements
SEGMENT
Filmed in Sydney and online | February 2025
INTERVIEWS
Professor David Hunter,
Florance and Cope Chair of Rheumatology
Co-Director Sydney Musculoskeletal Health Flagship,
University of Sydney
Dr Bincy Thampi,
Medical & Scientific Affairs Lead
Haleon ANZ
Osteoarthritis is a leading cause of disability affecting over 2 million Australians, according to Australian Institute of Health and Welfare report on Chronic musculoskeletal conditions (2024) and 595 million people globally, according to BD 2021 Osteoarthritis Collaborators. Global, regional, and national burden of osteoarthritis, 1990–2020. It represents a significant public health burden that diminishes quality of life among ageing populations.
Consumer healthcare company Haleon is sponsoring a five-year named fellowship program at the University of Sydney that will investigate the therapeutic role of supplements in managing osteoarthritis symptoms and digital health technologies that improve mobility.
The fellowship will fund a postdoctoral researcher to work under the guidance of world leading osteoarthritis expert, rheumatologist and researcher Professor David Hunter.
Australian Health Journal spoke with Professor Hunter who said the research collaboration represents a shared focus and investment in improving osteoarthritis management: “This is a disabling disease that has a huge impact on the people affected.”
“A collaborative effort between researchers and manufacturers will drive innovation and hopefully improve the lives of those impacted by this devastating disease. Use of supplements and natural ingredients in managing osteoarthritis is an exciting area with a lot of potential. I’m not aware of any other long-term, five-year projects of this nature that has osteoarthritis as its focus,” said Hunter.
Haleon and the University of Sydney have a shared goal of finding better management strategies for osteoarthritis and developing better outcomes for the people affected.
Dr Bincy Thampi, Medical & Scientific Affairs Lead at Haleon ANZ, also spoke with Australian Health Journal and says, “Haleon has a strong commitment to scientific research that drives innovative self-care and improves consumer health outcomes.”
“This partnership illustrates Haleon’s commitment to advancing trusted science for our products to better everyday health and we’re excited to see where this partnership with University of Sydney leads,” said Dr Thampi.
-
Clinical entrepreneur addresses needle-phobia
Australian entrepreneur, Lauren Barber, turned her nursing background into the role of an inventor and launched a medical device into the Australian healthcare industry.
No journey is linear for an entrepreneur, but Lauren has travelled considerable distance from a nursing student to a successful entrepreneur illustration her determination and passion to help those with needle phobias. Lauren’s work with NeedleCalm is making a positive impact in the healthcare industry and improving the experiences of patients and clinicians alike.
-
Peak body in child and family services urges prioritising healthcare for kids in care
The Centre for Excellence in Child and Family Welfare (the Centre) is calling on the Australian Government to prioritise healthcare access for children in out-of-home care.
“We have many amazing young people in care with huge potential, but they’re not set up for success,” said Deb Tsorbaris, CEO “Young people and workers tell us that access to health and education assessments is a huge disadvantage.”
-
Awareness campaigns and HCP Toolkits for thyroid health
In 2021, the Australian Thyroid Foundation released analysis to show, well over 1 million Australian are living with an undiagnosed thyroid disorder, including thyroid cancer, lower IQs, lifelong disability, and a causal or possible contributory factor – in the development of other neurological disorders such as ADHD and autism. Some of the challenges for diagnosis and treatment can be addressed by producing material for health care practitioners during patient presentations.
‘Recent statistics show well over 1 million Australians are living with an undiagnosed thyroid disorder, awareness and testing can prevent unwarranted outcomes for mothers and their babies’ says ATF CEO Beverley Garside OAM
The Australian Thyroid Foundation has lodged a Pre-Budget Submission for the Federal Budget 2024-25 to counter increasing misinformation on social media creating dietary deficiencies such as an increasing number of young women, who are planning pregnancy or already pregnant opting for plant based milks such almond, soy or oat milk coffee as an alternative to standard cow’s milk, which is a source of iodine and alternate milks do not include.
